Freenome has introduced SimpleScreen Lung, a blood test for lung cancer screening in adults aged 50-80 with a significant smoking history, alongside its FDA-approved SimpleScreen CRC test for colorectal cancer. This combined approach allows eligible patients to be screened for both cancers in a single blood draw, potentially increasing screening rates and early detection. SimpleScreen Lung showed 85% sensitivity and a 99.8% negative predictive value in clinical validation. The tests aim to improve access and participation in cancer screening, addressing the low current screening rates for lung and colorectal cancers in the U.S.
Freenome's new cancer detection tests provide context for health sector trends. For readers following health stocks, here is Pluang's market snapshot as of Oct 20, 2026 19:03 WIB: 81 of 150 US health stocks rose, 62 fell. Sanofi SA (SNY) gained 2.53% to USD 40.57 with a typical hold time of 95 days. Crispr Therapeutics AG (CRSP) dropped 2.18% to USD 48.95, with 83% buy orders and a typical hold time of 78 days. Elanco Animal Health (ELAN) fell 2.13% to USD 22.99, held typically for 11 days.
Hershey is preparing to announce its Q3 earnings on October 29, with analysts forecasting earnings per share (EPS) of $2.12, a 63% increase from last year, and revenue of $3.25 billion, up 2.3%. The company has shown strong recent performance, with Q...
3M reported strong Q3 2026 earnings with adjusted EPS of $2.50, beating estimates of $2.38, and GAAP profit rising to $1.37 billion from $834 million a year earlier. Sales reached $6.6 billion, slightly below estimates, but showed 3.3% organic growth...
Alaska Air Group is set to report Q3 2026 earnings with analysts expecting a 66.7% drop in earnings per share to $0.35, despite a 14.5% increase in revenue to $4.31 billion driven by strong travel demand. Passenger revenue is forecast to rise 10.2%, ...
Baba, an applied AI company focused on modernizing Medicare and Medicaid care, has raised $40 million in a Series A funding round led by FirstMark Capital, with participation from CVS Health Ventures and others. The funding will help Baba expand its ...
Richard Campbell-Breeden, a seasoned investment banker with 37 years of experience including 27 years at Goldman Sachs, has joined SEDA Experts LLC as Managing Director. His expertise in mergers and acquisitions, corporate finance, and governance wil...
